Schedule At A Glance

Document Sample
Schedule At A Glance Powered By Docstoc
					Schedule-At-A-Glance
Click here for the Complete Meeting Program


Monday, May 26, 2008
 8:30 a.m.-5:00 p.m.      New Investigators’ Workshop (closed session)
 2:00 p.m.-5:00 p.m.      Registration

Tuesday, May 27, 2008
 7:30 a.m.-9:00 a.m.      Continental Breakfast
 7:30 a.m.-5:15 p.m.      Registration

Concurrent Sessions       Workshop 1:                Workshop 2:                   Workshop 3:             Workshop 4:
 9:00 a.m.-12:00 p.m.     Enhancing Precision in     How an Idea Becomes           Geriatric               Beyond ECT: The
                          Clinical Trials XI         an NIMH-Funded Grant          Psychopharmacology:     Challenges of New
                          Part 1: Study Design:                                    Predicting Response,    Somatic Treatment
                          Methods and                                              Side Effects, and       Research
                          Methodologies                                            Safety


Concurrent Sessions       Workshop 1:                Workshop 5:                   Workshop 6:             Workshop 7:
 1:30 p.m.-5:15 p.m. 	    Enhancing Precision in     The Role of Clinical          Global Assessments in   Psychopharmacology
                          Clinical Trials XI         Trials in Informing           CNS Clinical Trials:    Education for
                          Part 2: Biomarkers and     Policy and Practice           Evolution and Future    Residents, Clinicians,
                          Pharmacogenetics                                                                 and Industry Personnel:
                                                     Part 1: Failed
                                                                                                           A Demonstration
                                                     Antidepressant Trials:
                                                     Causes and Solutions
                                                     Part 2: Dissemination
                                                     of Clinical Trials Results:
                                                     A Necessary Step
                                                     Toward Personalized
                                                     Treatment

 6:00 p.m.-7:30 p.m. 	    New Investigators’ Award Ceremony and Reception (By Invitation Only)


Wednesday, May 28, 2008
 7:30 a.m.-8:30 a.m. 	    Continental Breakfast
 8:00 a.m.-5:30 p.m. 	    Registration
 8:45 a.m.-12:00 p.m. 	    Welcome from NIMH and ASCP
                          Plenary Session: The Art and Science of Personalizing Treatments for Mental Disorders

Concurrent Sessions       Poster Session:            NIMH Program
12:00 p.m.-2:00 p.m.      Poster Session 1           Session 1:
                                                     ClinicalTrials.gov, What
                                                     You Need to Know
Schedule-At-A-Glance
Wednesday, May 28, 2008 (continued)
Concurrent Sessions       Panel 1:                 Panel 2:                  Panel 3:                 Panel 4:
 2:00 p.m.-3:30 p.m.      Treatment of             Combined Treatments       Enhancing Signal         Quality Indicators in the
                          SSRI-Resistant           for Depression and        Detection in             Practice of
                          Depression in            Anxiety Disorders         Depression Clinical      Psychopharmacology
                          Adolescents (TORDIA)                               Trials: Focus on Early
                                                                             Research


Concurrent Sessions       Individual Research      Panel 5:                  Panel 6:                 Panel 7:
 4:00 p.m.-5:30 p.m.      and Late-breaking        Redefining Mood           Is there a Link          Patient-Reported
                          News Reports             Disorders in Clinical     Between                  Outcomes in CNS
                                                   Drug Development          Antipsychotic            Clinical Trials: The
                                                                             Adverse Effects and      Importance of
                                                                             Efficacy in the          Validation from
                                                                             Treatment of             Scientific and
                                                                             Schizophrenia?           Regulatory
                                                                                                      Perspectives
7:00 p.m.-9:00 p.m.       NIMH/ASCP Reception (Open) 


Thursday, May 29, 2008
6:30 a.m.-8:00 a.m.       10th Annual NCDEU Fun Run and Walk

7:30 a.m.-8:30 a.m. 	     Continental Breakfast

8:00 a.m.-5:30 p.m. 	     Registration

Concurrent Sessions: 	    Panel 8:                Panel 9:                  Panel 10:                 Panel 11:
 8:30 a.m.-10:00 a.m. 	   Toward a Personalized   Innovations in CNS        Integrating Results of    New Trends in
                          Approach to ADHD        Clinical Trials Designs   Ethnicity/Race            Biostatistics
                          Pharmacotherapy                                   Treatment Outcomes
                                                                            Across STAR*D,
                                                                            STEP-BD, and CATIE
                                                                            NIMH Clinical Trials


Concurrent Sessions: 	    Panel 12:               Individual Research       Panel 13:                 Panel 14:
10:30 a.m.-12:00 p.m. 	   Suicidality and         and Late-breaking         Could there be a Role     Drug Safety and
                          Depression Treatment    News Reports              for Beta-Amyloid          Pharmacovigilence
                                                                            (Abeta) Lowering
                                                                            Drugs in the Treatment
                                                                            of Late-Life
                                                                            Depression?


Concurrent Sessions:      Poster Session:         NIMH Program
12:00 p.m.-2:00 p.m.      Poster Session 2        Session 2:
                                                  NIMH, the Media,
                                                  and You
Schedule-At-A-Glance
Thursday, May 29, 2008 (continued)
Concurrent Sessions:   Panel 15:                Panel 16:                Panel 17:               Individual Research
 2:00 p.m.-3:30 p.m.   Child and Adolescent     Balancing                The Time Course of      and Late-breaking
                       Anxiety Multimodal       Generalizability         Antipsychotic           News Reports
                       Study: Acute             and Assay                Response: Evidence,
                       Phase Efficacy and       Sensitivity in Bipolar   Mechanisms, and
                       Safety Results           Treatment Trials         Implications for
                                                                         Clinical Care

Concurrent Sessions:   Panel 18:                Panel 19:                Panel 20:               Individual Research
 4:00 p.m.-5:30 p.m.   Ethics Applications in   The Latest               New Research on Long-   and Late-breaking
                       Child and Adolescent     Developments in the      Acting Injectable       News Reports
                       Psychopharmacology       Assessment of            Antipsychotics in
                       Clinical Research        Cognitive Impairments    Clinical Practice
                       and Practice             and Functional
                                                Disability in Clinical
                                                Treatment Studies

Friday, May 30, 2008
8:00 a.m.-9:00 a.m.    Continental Breakfast
9:00 a.m.-12:00 p.m.   Food and Drug Administration Symposium


Click here for the Complete Meeting Program 





                                                                                                     5/22/08